Study of the Nevisense Device to Assess Atypical Skin Lesions

Memorial Sloan Kettering Cancer Center40 enrolled

Overview

The purpose of this study is to find out whether the Nevisense device can provide useful information about atypical moles to complement the usual assessments done during routine screening for melanoma. Assessing particpants' moles with the Nevisense device may help improve screening methods for the early detection of melanoma in people with atypical mole syndrome.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Nevus Multiple Nevi Large Acquired Nevi Skin Lesion

Interventions

Nevisense electrical impedance spectroscopyDIAGNOSTIC_TEST

Each participants will undergo Nevisense electrical impedance spectroscopy in order to characterize the electrical impedance spectroscopy scores of nevi in patients with ≥ 100 nevi on the entire cutaneous surface and at least three large acquired nevi (LAN) \> 5 mm in diameter

Eligibility

Sex: ALLMin age: 30 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Adult patients (\> 30 years of age) at the time of the initial study visit. * Patients displaying a phenotype that consists of ≥ 100 nevi on the entire cutaneous surface and at least three large acquired nevi (LAN) \> 5 mm in diameter. These patients have "atypical mole syndrome", which is a high-risk nevus phenotype and the target patient population in this study. * Patients with at least three clinically stable nevi between 5 and 20 mm in diameter. * Patients (or LAR) who are able to provide informed consent. * Patients with previous total body photography images taken at least 3 years prior Exclusion Criteria: * Patients without at least three clinically stable nevi between 5 and 20 mm in diameter. * Patients with any electronic implantable devices. * Patients who are pregnant (verbally confirmed with the participant).

Locations (3)

Memorial Sloan Kettering Basking Ridge (Consent only)

Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Westchester (Consent only)

Harrison, New York, United States

Memorial Sloan Kettering Cancer Center (All Protocol Activities)

New York, New York, United States

Outcomes

Primary Outcomes

Electrical impedance spectroscopy scores of participants' nevi

The primary objective is to characterize the electrical impedance spectroscopy scores of nevi in patients with ≥ 100 nevi on the entire cutaneous surface and at least three large acquired nevi (LAN) \> 5 mm in diameter.

Time frame: 2 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.